The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study
Publication
, Journal Article
Felker, GM; Leimberger, JD; Cuffe, MS; Gheorghiade, M
Published in: CIRCULATION
October 23, 2001
Duke Scholars
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 23, 2001
Volume
104
Issue
17
Start / End Page
571 / 572
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Felker, G. M., Leimberger, J. D., Cuffe, M. S., & Gheorghiade, M. (2001). The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study. CIRCULATION, 104(17), 571–572.
Felker, G. M., J. D. Leimberger, M. S. Cuffe, and M. Gheorghiade. “The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study.” CIRCULATION 104, no. 17 (October 23, 2001): 571–72.
Felker GM, Leimberger JD, Cuffe MS, Gheorghiade M. The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study. CIRCULATION. 2001 Oct 23;104(17):571–2.
Felker, G. M., et al. “The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study.” CIRCULATION, vol. 104, no. 17, LIPPINCOTT WILLIAMS & WILKINS, Oct. 2001, pp. 571–72.
Felker GM, Leimberger JD, Cuffe MS, Gheorghiade M. The combination of digoxin and milrinone therapy is not associated with an increased risk of adverse outcomes in patients hospitalized for heart failure: Results from the OPTIME-CHF study. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2001 Oct 23;104(17):571–572.
Published In
CIRCULATION
ISSN
0009-7322
Publication Date
October 23, 2001
Volume
104
Issue
17
Start / End Page
571 / 572
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Related Subject Headings
- Cardiovascular System & Hematology
- 4207 Sports science and exercise
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology